World Bank to assess MP’s healthcare system for upgradation: Dy CM

Posted on by Vividh Bharathi

Bhopal, Dec 10 (IANS) Madhya Pradesh Deputy Chief Minister Rajendra Shukla on Tuesday said he has urged the World Bank to conduct a thorough assessment of the state’s current healthcare challenges.

He said the World Bank’s study would provide a solid foundation for understanding the existing gaps in the healthcare system and implementing corrective measures.

Shukla, who is also the Health minister of Madhya Pradesh, informed that the delegation has assured to conduct an in-depth study on the state’s healthcare system and will provide its report by March 2025.

Shukla made this statement after chairing a meeting with a delegation of the World Bank representatives here in Bhopal on Tuesday. “World Bank will conduct a comprehensive assessment and propose reforms to empower the state’s healthcare system,” he added.

During the meeting discussion held on various subjects pertaining to the state’s health infrastructure, including the study of health indicators, the rising prevalence of non-communicable diseases (NCDs) and a geographical analysis of disease distribution.

He asserted that addressing the shortage of specialist doctors and other medical manpower in rural areas is a critical challenge that requires both medical and non-medical interventions.

Shukla stressed the importance of optimising the use of healthcare services and resources to ensure that these facilities are accessible to all sections of society.

“The state government is committed to providing timely, accessible, and high-quality healthcare services to every citizen in the state. All possible efforts are being made to strengthen our health infrastructures,” Shukla said.

He informed me that the state government has decided to develop community health centres (CHCs) into first referral units (FRUs) with advanced systems and adequate manpower required for it.

Additionally, medical colleges are being expanded, and large-scale recruitments are being carried out to strengthen the healthcare workforce. He reiterated that these measures aim to improve healthcare delivery and elevate the state’s health indicators.

–IANS

pd/dan

Related Posts

Diabetes, inflammation can make your brain age faster, up dementia risk: Study

New Delhi, Dec 21 (IANS) Brains of people with high glucose levels and inflammation can age faster, increasing their risk of developing dementia, according to a study.

Researchers at Karolinska Institutet in Sweden used an artificial intelligence (AI) tool to analyse brain images from 739 cognitively healthy people aged 70-years to explore the brain’s biological age.

They found various risk and health factors that determine the speed at which the brain ages.

The study, presented in the journal Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, showed that diabetes, stroke, cerebral small vessel disease, and inflammation were linked to brains with an older appearance,

On the other hand, healthy lifestyles involving regular exercise were linked to brains with a younger appearance, the study added.

The team conducted MRI scans of the participant’s brains and then estimated the age of the resulting brain images using their AI-based algorithm. Further, blood samples were taken for measuring lipids, glucose, and inflammation; and their cognitive abilities were also tested.

The AI tool estimated the brain age for both sexes to be on average 71 years. The researchers then looked at the ”brain age gap” by subtracting the participants’ estimated biological brain age from their chronological age.

“A take-home from the study is that factors that adversely affect the blood vessels can also be related to older-looking brains,” said lead author Anna Marseglia, a researcher at the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet.

This “shows how important it is to keep your blood vessels healthy, to protect your brain, by making sure, for instance, that your blood glucose level is kept stable,” Marseglia added.

The team next aims to launch a study to understand how women and men may differ in how they build resilience,

–IANS

rvt/

Mission Vatsalya scheme supports 2,450 child care institutes: Centre

New Delhi, Dec 11 (IANS) The Centrally sponsored Mission Vatsalya scheme has supported 2,450 child care institutions (CCIs) during FY 2023-24 for providing institutional care services to children, said Minister of State for Women and Child Development Savitri Thakur, in the Rajya Sabha on Wednesday.

Under the Mission, 1,21,861 children were supported for non-institutional care, while 62,594 children were given institutional care.

The CCIs provide age-appropriate education, access to vocational training, recreation, health care, and counseling.

The scheme was launched in 2021 by the Ministry of Women and Child Development (WCD) to support children in need of care and protection (CNCP) and children in conflict with law (CCL).

“The objective of Mission Vatsalya is to ensure that the best interests of children are always taken care of while designing the projects/ programmes,” Thakur said, adding that it also aims to establish “essential services, emergency outreach services for children and include strengthening of institutional and non-institutional care services”.

The MoS said that there are 762 district child protection units, 781 child welfare committees, and 774 juvenile justice boards in the country.

Thakur said that 3,580 children were adopted in-country and 449 children were adopted inter-country during FY 2023-24.

Further, Thakur also informed that more than 81.64 lakh women were assisted through the women’s helpline till October 31.

“Women helpline aims to provide 24x7x365 emergency and non-emergency response through telephonic short-code 181 to women, both in public and private spaces,” the MoS said.

The Women Helpline (WHL) scheme has been implemented since April 1, 2015.

Meanwhile, over 10 lakh women are assisted by 802 One Stop Centres (OSC), Mission Shakti.

The OSC, operational across the country, provides integrated support and assistance under one roof to women affected by violence and those in distress, both in private and public spaces.

It also provides services like medical aid, legal aid and advice, temporary shelter, police assistance, and psycho-social counseling to needy women.

“Out of the approved 878 One Stop Centres (OSCs), 802 OSCs are operational across the country, and over 10.12 lakh women have been assisted till October 31,” Thakur said.

–IANS

rvt/pgh

1st malaria vaccine shows promise against rising cases: Report 

New Delhi, Dec 19 (IANS) The first blood-stage malaria vaccine RH5.1/Matrix-M has the potential to be a component within a developing malaria vaccine strategy, said a report on Thursday.

The report by GlobalData, a data and analytics company, showed that there are 11 other malaria vaccines currently in Phase II development.

As per a recent study by researchers in Burkina Faso and the UK, RH5.1/Matrix-M is safe, effective, and highly immunogenic.

The double-blind, randomised, controlled, phase 2b trial, analysed 361 children between the ages of 5 and 17 months showed that RH5.1/Matrix-M is 55 per cent effective against clinical malaria when administered in a delayed third-dose regimen at 0, 1, and 5 months.

Further, the vaccine demonstrated over 80 per cent efficacy against high levels of malaria parasites, which indicates the vaccine would be effective at preventing severe disease. RH5.1/Matrix-M was found to be generally safe and well-tolerated, with no serious adverse events being reported, revealed the findings published in The Lancet Infectious Diseases.

“RH5.1/Matrix-M has the potential to be the first blood-stage malaria vaccine brought to market. This could be a much-needed addition to the currently available malaria vaccines and provide an important second line of defense for those most at risk of contracting malaria,” said Stephanie Kurdach, Infectious Disease Analyst at GlobalData.

Malaria is a mosquito-borne disease, caused by parasitic Plasmodium protozoans, spread primarily through the bite of an infected female Anopheles mosquito. Typically, the symptoms can range from fever, chills, and headache to confusion, seizures, and difficulty breathing.

Kurdach noted that although there is progress and some nations have been certified as malaria-free, the burden of malaria remains high, particularly within the World Health Organization’s (WHO) African Region.

There are currently only two malaria vaccines, that are WHO prequalified and recommended for use in children: GSK’s Mosquirix and Serum Institute of India’s R21/Matrix-M.

These vaccines work to intercept malaria infection by targeting the early sporozoite stage of the parasite.

However, as immunity wanes with time, sporozoites can infect the liver and lead to blood-stage clinical malaria infection.

The development of a blood-stage malaria vaccine would replace these vaccines as well provide a second line of defense.

“There are 11 other malaria vaccines currently in Phase II development, including pre-erythrocytic vaccines and blood-stage vaccines from manufacturers such as BioNTech, GSK, the National Institute of Allergy and Infectious Diseases (NIAID), and Vac4All SAS,” Kurdach said

“No new malaria vaccines are in Phase III development or pre-registration at this time,” she added.

–IANS

rvt